PKBO
Price:
$0.0225
Market Cap:
$520.31K
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situa...[Read more]
Industry
Biotechnology
IPO Date
2021-03-15
Stock Exchange
NASDAQ
Ticker
PKBO
According to Peak Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 519.80K. This represents a change of -82.09% compared to the average of 2.90M of the last 4 quarters.
The mean historical Enterprise Value of Peak Bio, Inc. over the last ten years is 44.63M. The current 519.80K Enterprise Value has changed 16.46% with respect to the historical average. Over the past ten years (40 quarters), PKBO's Enterprise Value was at its highest in in the June 2022 quarter at 201.92M. The Enterprise Value was at its lowest in in the September 2018 quarter at 0.
Average
44.63M
Median
8.11M
Minimum
0
Maximum
196.66M
Discovering the peaks and valleys of Peak Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 196.66M
Minimum Annual Increase = 0%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 0 | -100.00% |
| 2023 | 15.88M | -79.94% |
| 2022 | 79.16M | -59.75% |
| 2021 | 196.66M | 202.40% |
| 2020 | 65.03M | 18.95% |
| 2019 | 341.35K | Infinity% |
| 2018 | 0 | 0% |
The current Enterprise Value of Peak Bio, Inc. (PKBO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
31.68M
5-year avg
71.35M
10-year avg
44.63M
Peak Bio, Inc.’s Enterprise Value is greater than BiomX Inc. (-313529.00), greater than Longevity Health Holdings Inc. (460.35K), greater than Phio Pharmaceuticals Corp. (-4600542.00), less than Infinity Pharmaceuticals, Inc. (9.83M), greater than Bellicum Pharmaceuticals, Inc. (-21058674.00), greater than Biocept, Inc. (-337214.00), greater than TFF Pharmaceuticals, Inc. (-5074061.00), less than Ontrak, Inc. (5.59M), less than Anew Medical, Inc. (16.87M), greater than TC Biopharm (Holdings) Plc (-470711.31),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -313529.00 | $854.47K | |
| 460.35K | $373.13K | |
| -4600542.00 | $12.43M | |
| 9.83M | $9.08K | |
| -21058674.00 | $778.33K | |
| -337214.00 | $450.79K | |
| -5074061.00 | $288.80K | |
| 5.59M | $2.34M | |
| 16.87M | $15.44M | |
| -470711.31 | $256.50K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Peak Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Peak Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Peak Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Peak Bio, Inc. (PKBO)?
What is the 3-year average Enterprise Value for Peak Bio, Inc. (PKBO)?
What is the 5-year average Enterprise Value for Peak Bio, Inc. (PKBO)?
How does the current Enterprise Value for Peak Bio, Inc. (PKBO) compare to its historical average?